Intercellular adhesion molecule-4 and CD36 are implicated in the abnormal adhesiveness of sickle cell SAD mouse erythrocytes to endothelium

Abstract

BackgroundAbnormal adhesiveness of red blood cells to endothelium has been implicated in vaso-occlusive crisis of sickle cell disease. The present study examined whether the SAD mouse model exhibits the same abnormalities of red blood cell adhesion as those found in human sickle cell disease. Design and MethodsThe repertoire of adhesive molecules on murine erythrocytes and bEnd.3 microvascular endothelial cells was determined by flow cytometry using monoclonal antibodies or by western blotting. Adhesion was investigated in dynamic conditions and measured at different shear stresses. ResultsCD36, CD47 and intercellular adhesion molecular-4, but not Lutheran blood group antigen/basal cell adhesion molecule, are present on mouse mature erythrocytes. a4β1 are not expressed on SAD and wild type reticulocytes. Endothelial bEnd.3 cells express aVβ3, a4β1, CD47, vascular cell adhesion molecule-1, and Lutheran blood group antigen/basal cell adhesion molecule, but not CD36. Adhesion of SAD red cells is: (i) 2-to 3-fold higher than that of wild type red cells; (ii) further increased on platelet activating factor-activated endothelium; (iii) not stimulated by epinephrine; (iv) inhibited after treating the endothelium with a peptide reproducing one of the binding sequences of mouse intercellular adhesion molecular-4, or with monoclonal antibody against murine av integrin; and (v) inhibited after pretreatment of red blood cells with anti-mouse CD36 monoclonal antibodies. The combination of treatments with intercellular adhesion molecular-4 peptide and anti-CD36 monoclonal antibodies eliminates excess adhesion of SAD red cells. The phosphorylation state of intercellular adhesion molecular-4 and CD36 is probably not involved in the over-adhesiveness of SAD erythrocytes. ConclusionsIntercellular adhesion molecular-4/avβ3 and CD36/thrombospondin interactions might contribute to the abnormally high adhesiveness of SAD red cells. The SAD mouse is a valuable animal model for investigating adhesion processes of sickle cell disease. Haematologica 2010;95:730-737. doi:10.3324/haematol.2009 Intercellular adhesion molecule-4 and CD36 are implicated in the abnormal adhesiveness of sickle cell SAD mouse erythrocytes to endothelium © F e r r a t a S t o r t i F o u n d a t i o n

Randomized phase 2 study of GMI-1070 in SCD: reduction in time to resolution of vaso-occlusive events and decreased opioid use

“…[7][8][9][10][11][12][13][14] Binding of both red cells and leukocytes to endothelial selectins has been proposed to have a critical role in SCD VOC. 13,[15][16][17] Endothelial E-selectin expression is upregulated by inflammatory cytokines and can become a target, along with P-selectin, for leukocyte adhesion.…”

PCL films of varying porosity influence ICAM‐1 expression of HUVECs

“…Moreover, ICAMs can also generate soluble ICAMs (sICAM‐1), via ectodomain shedding, which is generally considered to be associated with endothelial injury or inflammation in vivo . These sICAM‐1 can compete for ligand binding sites with native mICAMs present on the cell surface and thus reduce cell adhesion . Thus, in this study, we selected ICAM‐1 as a marker to explore the relationship among the expression of ICAM‐1, pore size of the micropore and cell adhesion.…”

Differential modulation of adhesion molecule expression by hydroxycarbamide in human endothelial cells from the micro- and macrocirculation: potential implications in sickle cell disease vasoocclusive events

“…35 However, Trinh-Trang-Tan et al, using sickle cell SAD mice, showed recently that erythrocyte CD36 contributes to the increased SAD RBC adhesion, while endothelial CD36 is not indispensable. 36 The issue is complex because CD36 is less strongly expressed on RBC from SAD than wild-type mice. Thus a potential CYinduced decrease of CD36 at the surface of HPMEC might not directly correlate with decreased adhesive properties in inflammatory conditions.…”